Stay updated on ARGX-113 in ITP Patients Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in ITP Patients Clinical Trial page.

Latest updates to the ARGX-113 in ITP Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to include a new version of the study protocol for ARGX-113 in treating Primary Immune Thrombocytopenia, with the revision noted as v2.15.0. Key details about the study's purpose and design have been removed, while collaborators and the EudraCT number have been added.SummaryDifference28%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to ARGX-113 in ITP Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in ITP Patients Clinical Trial page.